Morcos, Michael http://orcid.org/0000-0003-3273-1230
Burgdorf, Christof
Vukadinivikj, Andrijana
Mahfoud, Felix
Latus, Joerg
Persson, Pontus B.
Schwenger, Vedat
Remppis, Andrew
Article History
Received: 22 May 2020
Accepted: 12 August 2020
First Online: 25 August 2020
Compliance with ethical standards
:
: Michael Morcos received honoraria from NovoNordisk, BerlinChemie, Sanofi Aventis, Bayer, Astra Zeneca and Amgen. Christof Burgdorf Andrijana Vukadinivikj and Joerg Latus have no conflicts of interest to declare. Felix Mahfoud reports grants from Deutsche Gesellschaft für Kardiologie (DGK), grants from Deutsche Forschungsgemeinschaft (DFG), grants and personal fees from Bayer, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Medtronic, grants and personal fees from ReCor Medical, outside the submitted work. Jörg Latus received honoraria from Amgen, Böhringer Ingelheim, Vifor, Fresenius Medical Care. Pontus P. Persson declares to have received honoraria from Bayer and RenalGuard Solutions regarding renal safety. Vedat Schwenger received honoraria from Fresenius Medical Care and Novartis. Andrew Remppis received honoraria from Novartis, Vifor, BerlinChemie, and RenalGuard Solutions.
: The present paper is not under consideration elsewhere and has not been published elsewhere. All authors have read and approved the manuscript.